Pierre-Yves Berclaz, Chief Science and Medical Officer at Ferring Pharmaceuticals, stated: "The ADAPT-1 trial results confirm the efficacy and safety of follitropin delta across the full range of ...

The human microbiome market is projected to grow at a CAGR of 31% over the forecast period. Major factors driving growth ...

Endometrial Cancer is a type of cancer that begins in the lining of the uterus, most commonly affecting postmenopausal women. Rising prevalence due to increasing obesity rates and aging population, ...

ImmunityBio’s ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.

Internal Medicine : Welcome to Medscape Internal Medicine, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles ...